TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
Q2 2025 vs. Q1 2025
How the institutions holding TriSalus Life Sciences, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 5 | −1 |
| Shares | 942.2K | 953.6K | +11.4K (+1.2%) |
| Value | $1.11M | $1.25M | +$135.1K (+12.1%) |
New holders (2)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 23,540 | $30.4K | 0.00% |
| Toronto Dominion Bank | 9,383 | $12.1K | 0.00% |
Sold out (3)
Institutions that held TriSalus Life Sciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Foster Victor Wealth Advisors, LLC | 12,601 | $14.6K |
| Wolverine Asset Management LLC | 8,735 | $10.6K |
| Bank of America Corp | 176 | $204 |